|Support type:||Scholarships in Brazil - Scientific Initiation|
|Effective date (Start):||December 01, 2012|
|Effective date (End):||November 30, 2014|
|Field of knowledge:||Health Sciences - Pharmacy - Pharmaceutical Technology|
|Principal Investigator:||Carolina Patrícia Aires|
|Grantee:||Ana Carolina dos Santos Ré|
|Home Institution:||Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil|
The biofilm is the etiological factor of most oral diseases as caries, gingivitis and periodontitis. In this regard, sustained release systems of drugs have been developed to the oral cavity in order to become less virulent biofilm. However, few studies have proposed models that simulate the conditions found in the mouth, such as bacteria organized in a biofilm. The objective of this study is to obtain a semi-solid-releasing drug that is feasible for the conditions considering the presence of oral bacteria, its extracellular products and the dynamics of staying in a liquid medium replacement daily. Thus, a system in situ gelation based on glyceryl monooleate is prepared and a metronidazole-containing formulation to be used as a standard tests aimed at obtaining a system able to provide stable preservation against biofilm of Streptococcus mutans. After the trial period for biofilm growth, it will be collected and homogenized by sonication. Viability is monitored by bacterial count of bacteria on BHI agar and the amount of drug remaining in the biofilm will be analyzed by HPLC. The formulation will be evaluated in relation to its mass, crystalline mesophase and the active residual. For comparison between groups, will initially be analyzed the homogeneity and variability of the results. The significance level of 5% is accepted.